Amid a surge in drug-resistant bacteria, researchers believe they have discovered a new class of antibiotics for the first ...

Lariocidin was efficient against strains of E. coli, including drug-resistant ones, according to the new study. View on ...

If you deal with recurrent UTIs, a new FDA-approved antibiotic called Blujepa could offer another treatment option—especially ...

That process led to the group discovering a lasso peptide that exhibited broad-spectrum antibiotic activity and was effective ...

Now, a team led by researchers at McMaster University in Ontario believe they’ve found a molecule that could lead to a whole ...

This antibiotic is the first new FDA-approved medication for urinary tract infections in decades, and meets the need for new ...

A new antibiotic has been approved to treat urinary tract infections by the Food and Drug Administration for the first time ...

Lariocidin is a newly discovered antibiotic from soil bacteria. It targets the bacterial ribosome, defeating resistant ...

Blujepa, which is made by the British pharmaceutical company GSK plc, is approved for the treatment of women and children ...

It is the first in a new class of oral antibiotics approved for this condition in nearly 30 years. UTIs are common bladder infections that typically affect women without underlying health issues.

The Food and Drug Administration has approved a new antibiotic that can treat uncomplicated urinary tract infections, or ...

For the first time in three decades, researchers believe they have identified a new class of antibiotics. Teams at McMaster University in Ontario, Canada and the University of Illinois ...